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STEM CELLS AND REGENERATION RESEARCH ARTICLE
Concealed expansion of immature precursors underpins acute
burst of adult HSC activity in foetal liver
Stanislav Rybtsov, Andrejs Ivanovs, Suling Zhao and Alexander Medvinsky*
ABSTRACT
One day prior to mass emergence of haematopoietic stem cells
(HSCs) in the foetal liver at E12.5, the embryo contains only a few
definitive HSCs. It is thought that the burst of HSC activity in the foetal
liver is underpinned by rapid maturation of immature embryonic
precursors of definitive HSCs, termed pre-HSCs. However, because
pre-HSCs are not detectable by direct transplantations into adult
irradiated recipients, the size and growth of this population, which
represents the embryonic rudiment of the adult haematopoietic
system, remains uncertain. Using a novel quantitative assay, we
demonstrate that from E9.5 the pre-HSC pool undergoes dramatic
growth in the aorta-gonad-mesonephros region and by E11.5
reaches the size that matches the number of definitive HSCs in the
E12.5 foetal liver. Thus, this study provides for the first time a
quantitative basis for our understanding of how the large population of
definitive HSCs emerges in the foetal liver.
KEY WORDS: AGM region, HSC, Embryo, Pre-HSC, Mouse
INTRODUCTION
Although the first signs of haematopoietic differentiation in mouse
development are observed in the embryonic day (E) 7.5 yolk sac of
the mouse embryo, definitive HSCs (dHSCs), which generate the
adult haematopoietic system and are detectable by direct
transplantation into adult irradiated recipients, emerge only by
E10.5-E11.5 in very small numbers (Kumaravelu et al., 2002;
Medvinsky and Dzierzak, 1996; Müller et al., 1994). However, by
E12.5 the foetal liver contains approximately 50-60 fully functional
dHSCs (Ema and Nakauchi, 2000; Kumaravelu et al., 2002). The
cellular processes underlying this dramatic rapid appearance of
dHSC activity in the foetal liver remain obscure.
Given that dHSCs that repopulate adult irradiated recipients
appear only by the end of E10, it is broadly understood that dHSCs
develop from immature HSC precursors (pre-HSCs), which are not
detectable by direct transplantation (Medvinsky and Dzierzak,
1996). However, the quantitative anatomy and dynamics of growth
of this embryonic rudiment of the adult haematopoietic system, is
not characterised.
In the E11.5 mouse embryo, the aorta-gonad-mesonephros
(AGM) region, placenta, extra-embryonic arteries, yolk sac and
head contain no more than one dHSC per tissue (de Bruijn et al.,
2000; Gekas et al., 2005; Gordon-Keylock et al., 2013; Kumaravelu
et al., 2002; Li et al., 2012; Mikkola et al., 2005; Müller et al., 1994;
Ottersbach and Dzierzak, 2005; Robin et al., 2009; Yoder et al.,
1997). Although various lines of evidence demonstrate a primary
role of the AGM region in different vertebrate species in HSC
development (Ciau-Uitz et al., 2014; Clements and Traver, 2013;
Dieterlen-Lievre, 1975; Dzierzak and Speck, 2008; Galloway and
Zon, 2003; Ivanovs et al., 2013, 2014, 2011; Medvinsky et al.,
2011, 1993; Müller et al., 1994), the contribution of other tissues
into the pool of adult HSCs is less clear. A key question regarding
the contribution of different tissues is which of them contain pre-
HSCs and, for those that do, how big is this population?
It has been possible to identify functionally the presence of pre-
HSCs by maturing pre-HSCs ex vivo (Medvinsky and Dzierzak,
1996; Rybtsov et al., 2011; Taoudi et al., 2008). Apart from the
AGM region, only large extra-embryonic arteries have been shown
to possess the potential to generate definitive HSCs de novo,
although to a lesser extent (de Bruijn et al., 2000; Gordon-Keylock
et al., 2013; Medvinsky and Dzierzak, 1996; Taoudi et al., 2008).
Previous experiments showed that the AGM region is a potent
source of HSCs. Although previously we and others demonstrated
quantitatively the massive dHSC outcome in culture, that approach
did not enable information about the initial (input) numbers of
HSC precursors (pre-HSCs) isolated from embryonic tissues to be
obtained (Hadland et al., 2015; Rybtsov et al., 2011; Taoudi et al.,
2008).
Here, we have sought confirmation that the size of the in vivo
pre-HSC pool is large enough to build the dHSC pool in the foetal
liver in less than 24 h. To this end, we designed a limiting dilution
approach to assess quantitatively the size of the pool of immature
HSC precursors in embryonic tissues in vivo, using an ex vivo
system (Fig. 1B).
Previous functional analysis identified VE-cadherin+ (cadherin 5)
cells, which sequentially upregulate CD41 (Itga2b), Runx1
(AML1), CD43 (Spn) and CD45 (Ptprc) haematopoietic markers,
as in vivo embryonic precursors of dHSCs (Chen et al., 2009;
Liakhovitskaia et al., 2014; Rybtsov et al., 2014, 2011). HSC
maturation from the endothelial compartment occurs through a four-
step process: pro-HSC→Type I pre-HSC→Type II pre-
HSC→dHSCs (Rybtsov et al., 2014, 2011; Taoudi et al., 2008).
Pro-HSCs were defined as VE-cad+CD41+CD43−CD45− cells,
Type I pre-HSCs as VE-cad+CD41lowCD43+CD45− cells and
Type II pre-HSCs as VE-cad+CD41lowCD43highCD45+ cells.
dHSCs have the same phenotype as Type II pre-HSCs (VE-
cad+CD41−/lowCD43highCD45+), but can be assayed by direct
transplantation into adult irradiated recipients. All four types of pre-
HSCs have been identified morphologically in the area of the dorsal
aorta (Rybtsov et al., 2014, 2011; Taoudi et al., 2008; Yokomizo
et al., 2011).
Here, using a novel quantitative approach (Fig. 1B; see also
Materials and Methods), we unveil for the first time an otherwiseReceived 23 September 2015; Accepted 29 February 2016
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concealed dramatic expansion of immature precursors that lay the
foundation of the adult haematopoietic system. Our data strongly
suggest that by E11.5 the size of the pre-HSC population in the
AGM region is sufficient to form the large dHSC pool in the foetal
liver through a quick maturation step.
RESULTS
Limiting dilution approach to quantify pre-HSCs
Although dHSCs have previously been quantitatively mapped in the
embryo using limiting dilution analysis (Fig. 1A) (Ema and
Nakauchi, 2000; Kumaravelu et al., 2002; Sutherland et al.,
1990), the numbers of pre-HSCs, which produce dHSCs in vivo
in these tissues, remained unknown. Here, we designed an ex vivo
approach to quantify pre-HSCs in vivo, which is based on a culture
system that allows all HSC precursor types to mature into fully
functional dHSCs (Rybtsov et al., 2014). Because pre-HSCs can
only be detected after a period of ex vivo culture, we diluted the pre-
HSC population to limiting dilution prior to ex vivo culture and
transplantation.
Specifically, cell suspensions obtained from dissected embryonic
tissues were divided into portions, each separately co-aggregated
with OP9 cells and cultured in conditions supporting pre-HSC
maturation. Importantly, our experimental design excludes any
contribution of cell proliferation (either by pre-HSCs or dHSCs)
into calculations of pre-HSC numbers. Namely, cultured co-
aggregates were transplanted individually into adult irradiated
recipients (one co-aggregate per mouse). In these circumstances,
any derivatives of a maturing pre-HSC or dHSCs remained
contained within their original co-aggregates and injected into an
individual recipient. Thus, if pre-HSC or dHSC expansion occurs in
culture, it is constrained by each co-aggregate, and does not
influence the number of positive co-aggregates. This allowed us to
determine retrospectively which co-aggregates contained no pre-
HSCs (i.e. gave no repopulation) and those which contained at least
one pre-HSC (i.e. gave repopulation) prior to culture (Fig. 1B). The
proportion of mice repopulated is used to count the number of pre-
HSCs in the initial undiluted (in vivo) population using extreme
limiting dilution analysis (ELDA; Hu and Smyth, 2009). For
conciseness, this assay will be termed here pre-HSC limiting
dilution assay (preHSC_LDA) (Fig. 1B; see also Materials and
Methods). Where the term pre-HSC is used in this paper, we are
referring to any of our previously defined non-repopulating
precursor cell types (pro-HSC, Type I pre-HSC and Type II pre-
HSC).
Identification of major sites of pre-HSC activity prior to liver
colonisation
In our initial experiments, preHSC_LDA showed that the E11 AGM
region, together with the anterior trunk containing the bifurcated
dorsal aorta (BA) and extra-embryonic vessels (EEVs), are enriched
for pre-HSCs (Fig. 1C,D). Indeed, all recipients transplanted with
whole individual co-aggregates containing one embryo equivalent
(ee) of the embryonic tissue were repopulated at high level with
donor-derived haematopoietic cells. Statistically, this means that
each E11.5 AGM region contained at least one pre-HSC. More
precise estimates derived from further dilutions will be described in
the next section. By contrast, transplantations of co-aggregates with
1 ee of other HSC niches, such as placenta (Pl) and head (H), gave a
proportion of non-repopulated mice (Fig. 1D), which allowed us to
apply preHSC_LDA and calculate that the E11.5 placenta contains
one or two pre-HSCs and the head contains zero or one pre-HSC per
embryo (Fig. S2B,D). Notably, we observed a tendency of
increasing pre-HSC numbers by the end of E11 in the placenta, in
linewith previous observations of placental dHSC dynamics (Gekas
et al., 2005). In all cases, long-term multi-lineage repopulation was
observed (Fig. S1A). Practically no pre-HSCs were detected in
somites and tail (S+T), body walls (BW), foetal liver (FL) or yolk
sac (YS) carefully separated from EEVs (Fig. 1D). Therefore, pre-
HSCs in the E11.5 embryo are predominantly localised to the AGM
region (Figs 1 and 2; see also Fig. S2B-D). Saturated repopulation
(lack of non-repopulated mice) with the AGM region, BA and EEVs
in these experiments does not allow preHSC_LDA to be used for
Fig. 1. Comparative limiting dilution analysis of pre-HSC
sites. (A) Standard limiting dilution analysis for dHSCs using
direct transplantations of freshly isolated cells. (B) Pre-HSC
limiting dilution assay (preHSC-LDA). AGM cell suspension
contains pro-HSCs and Type I pre-HSCs (green circles), Type II
pre-HSCs (orange circles) and dHSCs (red circles). Each whole
co-aggregate was injected in an individual recipient (one co-
aggregate per mouse). Note that 0.01 ee dose for co-
aggregation is indicated as an example and varied in actual
experiments. For further description, see Materials and
Methods. (C) Dissection boundaries (green dashed lines) of
cultured and transplanted tissues (E11.5). Position of the dorsal
aorta (including bifurcated rostral part) is shown by thick orange
line. (D) Tissue distribution of pre-HSCs. Each isolated tissue
(as indicated in C) was co-aggregated individually with OP9
cells, cultured and each co-aggregate transplanted individually
into a recipient (1 ee/co-aggregate/recipient). Blue diamonds
represent donor-derived blood chimerism (%) in individual mice.
Numbers of non-repopulated mice were used for quantification
of pre-HSC as described in Materials and Methods for
preHSC_LDA. AGM, aorta-gonad-mesonephros; BA,
bifurcated dorsal aorta; BW, body wall; EEV, extra-embryonic
vessels; FL, foetal liver; H, head; Pl, placenta; S, somites; T, tail;
YS, yolk sac.
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precise assessment of pre-HSC numbers in these tissues (Fig. 1D).
To this end, higher cell dilution doses have been used as described
below. Because both the AGM region and the more rostrally located
BA are significantly enriched for pre-HSCs (Fig. 1C,D), further
investigations of these anatomically linked parts were performed as
a single entity.
Pre-HSC pool expands rapidly between E9.5 and E11.5
To investigate developmental dynamics of pre-HSC expansion
in vivo, we assessed pre-HSC numbers at several developmental
time points (stages) from E9 to E12.5 using preHSC_LDA (Fig. 2;
Table S2). Embryos were staged according to the number of somite
pairs (sp). We found that the E9.5 caudal part contains no more than
one or two pro-HSCs (Fig. 2A). By E10 we observed a steady and
rapid increase in pre-HSC numbers from approximately five at early
E10 up to 20-30 by mid-E10 (35 sp) and ∼50 by the end of E10
(39 sp). During E11 pre-HSC numbers reached a peak of 65 cells
and by E12.5 the number of pre-HSCs dramatically dropped to
about ten, likely reflecting their shift to the foetal liver (Fig. 2). Pre-
HSCs in extra-embryonic arteries begin to emerge from late E10.5,
and by E11 reach 15 cells (Fig. 2B). Therefore, our estimates show
that by late E11 the embryo contains ∼70 pre-HSCs in total (54
preHSCs and 15 preHSCs in the AGM region and EEV,
respectively). Comparable numbers of pre-HSCs at E11.5 were
obtained in two additional limiting dilution experiments with whole
caudal parts and extra-embryonic vessels (Fig. S2A).
We found that the E11.5 foetal liver entirely lacks pre-HSC or
dHSC activity (Fig. 2C). By the following day, the number of dHSC
in the foetal liver (as assessed by direct transplantation) is 30 and
reaches 120 by late E12. Although low level repopulating activity
was reported in Rag2γc−/− mice from an earlier foetal liver that was
cultured in the presence of thrombopoetin on OP9 cells (Kieusseian
et al., 2012), the relation of these cells to the definitive HSC lineage
remains unclear. Of note, in the E12.5 foetal liver numbers of cells
calculated by the preHSC_LDA over sequential somite pair stages
closely coincide with respective dHSCs numbers assessed by direct
transplantations.
Because dHSCs are supported in these culture conditions (as tested
on adult bone marrow HSCs, data not shown) their numbers also
contributed to preHSC_LDA estimates. Therefore, to obtain actual
numbers of pre-HSCs, dHSC numbers detected in vivo by direct
transplantations have to be subtracted from preHSC_LDA estimates.
Such mathematical procedure does not change significantly pre-HSC
numbers in the AGM region owing to absence or low numbers of
dHSCs. However, in the foetal liver numbers of dHSCs (Fig. 2C, red
line) and those obtained by preHSC_LDA (Fig. 2C, dashed green
line) coincide and therefore, by deduction, this strongly suggests that
the E12.5 liver contains only dHSCs and no pre-HSCs.
Remarkably, the number of pre-HSCs in E11.5 AGM region
assessed by preHSC_LDA coincides with dHSC numbers in the
E12.5 foetal liver (identified by direct transplantations). Thus,
despite the considerable presence of VE-cad+ cells in the foetal
liver, they are not related to dHSCs, in line with the view that the
liver is colonised from outside.
The quantitative matching of pre-HSC numbers in the AGM
region and dHSC numbers in the foetal liver allows us to conclude
with high confidence that the ex vivo HSC maturation system does
not artificially stimulate dHSC generation from cells outside the pre-
HSC lineage. However, this quantitative matching also suggests that
practically all immature pre-HSCs are captured, strongly indicating
that the ex vivo assay employed here adequately identifies pre-HSC
populations in vivo.
Composition dynamics of the developing HSC pool
We next investigated the composition dynamics of the developing
HSC hierarchy throughout E9.5-E12.5 stages. Fig. 3A,B illustrates
pre-HSC development in the AGM region followed by
accumulation of the dHSC pool in the foetal liver. The ratio
between the earliest CD45− (pro-HSC and Type I pre-HSC) and
more advanced CD45+ (Type II pre-HSC) embryonic precursors
was assessed. To this end, we sorted E10.5 VE-cad+CD45− and VE-
cad+CD45+ populations and co-aggregated them with OP9 stromal
cells (Fig. S1B). After culture, co-aggregates were pooled and
transplanted into irradiated recipients, confirming that 30-38 sp
(E10) AGM regions contain only CD45− HSC precursors. We
found that Type II pre-HSCs appear only after the end of E10
(Fig. S1B) (Rybtsov et al., 2011). At E11.5, the AGM region still
contains Type I pre-HSCs, but also develops Type II pre-HSCs
(Rybtsov et al., 2011). To evaluate the ratio between Type I pre-
HSCs and Type II pre-HSCs at this stage, these populations were
sorted and co-aggregated with OP9 cells in limiting dilutions. Using
preHSC_LDA (Fig. 1B), we established that the quantitative Type I
to Type II pre-HSC ratio is 1:4 (all embryos are 41-45 sp; n=6
Fig. 2. Quantitative developmental dynamics of pre-HSCs and HSCs in
early embryo. (A-C) Dynamics of pre-HSC (green) and dHSC (red) numbers
in caudal part/AGM region (A), extra-embryonic vessels (B) and foetal liver (C).
Predicted polynomial regression curve, equation and correlation (R2) for pre-
HSCs (green) and dHSCs (red) for each tissue are shown. Days post-
fertilisation are indicated along the top and somite counts are along the lower
axis. Each symbol represents a pre-HSC/dHSC number obtained from an
individual experiment. Note that each symbol represents pre-HSC or HSC
number in an individual experiment (not in an individual animal) calculated by
preHSC_LDA (in green) or dHSC LDA (in red; as assayed by direct
transplantations of fresh tissues); for methodology see Fig. 1B and 1A,
respectively. For example, the curve for pre-HSCs in the AGM region
represents 27 experiments. Full summary of experiments with repopulation
levels of individual mice is presented in Table S2. Note that green dashed line
(marked by asterisk) (C), represents pre-existing dHSCs in the foetal liver,
which are maintained in culture, as numbers coincide with those calculated by
direct transplantations shown in red (for detailed explanation, see Results).
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experiments) (Table S1). As the average number of pre-HSCs in the
AGM region at this stage is 54±5.8 (Fig. 3B; Table S2), the
quantitative composition of the HSC hierarchy (pre-HSC Type I:
pre-HSC Type II: dHSC) is 11:42:1, given the presence of
approximately one dHSC as detected by direct transplantation
(Fig. 2A) (Kumaravelu et al., 2002; Taylor et al., 2010). By E12, the
AGM region still contains Type II pre-HSCs; however, Type I pre-
HSCs are no longer detectable, suggesting that de novo pre-HSC
formation is finished (Fig. S1C).
DISCUSSION
Previous reports using newborn recipients indicated the presence of
1-12 pre-HSCs in the E10-E11 AGM region (Arora et al., 2014;
Boisset et al., 2014). Our study gives significantly higher numbers,
which could be explained by: (1) use of the highly controlled and
efficient ex vivo HSC maturation system and (2) robust homing of
mature dHSCs into adult recipients, compared with engraftment of
immature pre-HSCs in newborn animals. As single adult bone
marrow HSCs can engraft at a very high frequency of 70-96% upon
intravenous injections (Kiel et al., 2005; Matsuzaki et al., 2004;
Wilson et al., 2008), this strongly indicates that the number of their
counterpart dHSCs matured from embryonic pre-HSCs in the
culture, is accurately estimated by intravenous transplantations.
The expansion of the pre-HSC population found here during
embryo development, in principle, can occur through their
proliferation as well as maturation from a more immature subset
of cells. Further development of experimental approaches will be
required to discriminate between these two scenarios.
At which anatomical location does the conversion of pre-HSCs
into dHSCs occur? At E11 we do not see active dHSC maturation in
the AGM region, but at E12 the liver is already full of dHSCs.
Several scenarios are possible: (1) although the first dHSCs appear
in the AGM region, sequential maturation of the following ones
occur followed by immediate relocation into the foetal liver (in this
case, large numbers of dHSCs would never be seen in the AGM
region but will gradually increase in the foetal liver); (2) a short
synchronous pulse of dHSC maturation inside the AGM region
occurs sometime between E11 and E12, e.g. during night time, but
this would be practically impossible to capture experimentally; (3)
pre-HSCs can gradually migrate through EEVs to the placenta
where they mature and subsequently relocate to the foetal liver. As
an indication for the third possibility, we see a tendency for pre-HSC
numbers in EEVs to increase towards the end of E11 (Fig. 2C). This
attractive possibility may link our data to previously published
studies (Gekas et al., 2005; Ottersbach and Dzierzak, 2005). The
first two scenarios imply that dHSC maturation occurs in the AGM
region prior to liver colonisation and would be in line with the
previous report showing that contact with the liver is not essential
for HSC maturation (Taoudi et al., 2005). Which scenario actually
takes place will need to be clarified in future studies.
In summary, our data show that between E9.5 and E11.5 the pool
of HSC precursors gradually matures and expands dramatically
predominantly in the AGM region and at lower levels in extra-
embryonic arteries. By E11.5, the size of the pre-HSC pool
remarkably matches the number of mature HSCs appearing within
less than 24 h in the foetal liver. Although some other embryonic
tissues also contain pre-HSCs, their numbers are negligible
compared with the AGM region. This finding offers a simple
explanation for the abrupt appearance of the large pool of definitive
HSCs in the foetal liver from pre-HSCs through a short maturation
step, which in principle does not require any significant
proliferation. The transition from the AGM region to the liver
stage is reflected by a rapid decrease of pre-HSCs in the AGM
region from 40-65 to ten, concurrent with a dramatic rise in the
mature dHSC pool in the foetal liver between E11.5 and E12.5
(Fig. 2A,C). Thus, this study unveils for the first time a unique,
previously unidentified cellular process that underlies the dynamic




Staged embryos were obtained by crossing C57BL/6 (CD45.2/2). The
morning of discovery of the vaginal plug was designated as E0.5. Accurate
embryo staging was performed by counting somite pairs (sp) and grouping
as follows: E9.0 (15-23 sp), E9.5 (24-30 sp), E10.0 (31-34 sp), E10.5 (35-
39 sp), E11.0 (40-45 sp) E11.5 (46-49 sp), E12.0 (51-55 sp), E12.5
(<56 sp). All experiments using animals were performed under a Project
Licence granted by the Home Office (UK), approved by the University of
Edinburgh Ethical Review Committee, and conducted in accordance with
local guidelines.
Long-term repopulation assay
Wild-type C57BL/6 CD45.2/2 cells were injected intravenously into adult
γ-irradiated CD45.1/2 heterozygous recipients [split dose (471+471 Rad)
with 3 h interval] along with 100,000 CD45.1/1 nucleated bone marrow
carrier cells per recipient.
Number of cells injected was expressed in embryo equivalents (ee). For
sorted cells, ee values were adjusted for percentage of dead cells. For
quantification of dHSC numbers, embryonic tissues isolated from different
developmental stages were dissected, dissociated and injected directly in
limiting dilutions into cohorts of recipients (Fig. 1A). Donor-derived
chimerism (%) was evaluated in peripheral blood at 6.5 weeks and
13.5-18 weeks post-transplantation using a FACSCalibur or Fortessa
(BD Biosciences) (our previous observations on >30 recipients of early
Fig. 3. Dynamic composition of pre-HSC/dHSC development. (A) Growing
pool of pre-HSCs in the AGM region builds up by E11.5 and rapidly colonises
the foetal liver (FL) by E12.5 (during 12-24 h) (cells are colour coded as in
Fig. 1). Ao, dorsal aorta. (B) Cumulative number of pro-HSCs and Type I pre-
HSCs (green area) relative to more mature Type II pre-HSCs (orange) and
dHSCs (pink), which appear and expand at later stages in the AGM region.
Numbers of AGM-derived pre-HSCs match dHSC numbers in E12 foetal liver
(brown). Foetal liver is represented by brown area; the AGM region is
represented by green, orange and pink areas. Each experimental point is the
mean of three or four experiments (standard deviations are shown) and derived
from Table S2 (calculated using preHSC_LDA). Ratio between pre-HSC Type I
and II derived from Table S1 and Fig. S1B,C.
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embryo-derived dHSCs matured in culture showed that repopulation at
13.5 weeks persists at least until week 18). Erythrocytes were depleted using
PharM Lyse (BD Biosciences) and cells were stained with anti-CD16/32
(Fc-block) followed by anti-CD45.1-APC (clone A20, cat. #12-0454-83)
and anti-CD45.2-PE (clone 104, cat. #17-0453-82) monoclonal antibodies
(eBioscience). Multi-lineage donor-derived haematopoietic contribution in
recipient blood and organs were determined by staining with anti-CD45.1-
V450 (cat. #560520), anti-CD45.2-V500 (cat. #562129) and lineage-
specific anti-Mac1 FITC (cat. #553310), Gr1-PE (cat. #553128) CD3e-APC
(cat. #553064), B220-PE-Cy7 (cat. #552772) monoclonal antibodies (BD
Pharmingen). We defined dHSCs as cells with long-term multi-lineage
repopulation capacity with chimerism >5% in recipient peripheral blood.
E9.5-E12.5 embryo dissection
Embryonic tissues were dissected as previously described for the AGM
region (Rybtsov et al., 2014, 2011; Taoudi et al., 2008), for extra-embryonic
vessels and yolk sac (Gordon-Keylock et al., 2013), for the placenta (Gekas
et al., 2005; Ottersbach and Dzierzak, 2005) and for the head (Li et al.,
2012). E11 AGM was dissected together with the BA (Fig. 1C).
Fluorescence-activated cell sorting and analysis
The following antibodies were used: anti-CD45 FITC (fluorescein
isothiocyanate; clone 30-F11, cat. #553080); anti-mouse VE-cadherin
biotin-conjugated antibody (clone 11D4.1, cat. #555289) following
streptavidin APC staining (all from BD Pharmingen). Cells were sorted
using a FACSAria-II sorter (BD Biosciences) followed by purity checks
as described before (Rybtsov et al., 2011). Gating of negative populations
was performed on the basis of fluorescence minus one (FMO) staining
where one of the antibodies was replaced with an isotype control (IC)
(BD Pharmingen). Dead cells were excluded by 7AAD staining. Data
acquisition and data analysis was performed by Fortessa (BD
Biosciences) using FlowJo software (Tree Star).
PreHSC_LDA
At the core of this method is the co-aggregation culture system, which allows
maturation of HSC precursors. In these culture conditions, all types of HSC
precursors isolated from E9.5-E11.5 embryos can mature into dHSCs
(Rybtsov et al., 2014). However, this approach does not allow pre-HSCs to
be quantified. Previously the limiting dilution approach (LDA) has
successfully been used for calculation of numbers of mature adult
haematopoietic stem cells (Fig. 1A) (Szilvassy et al., 2002).
Our novel approach, termed preHSC_LDA, is designed here to assess
pre-HSC numbers present in vivo (Fig. 1B). For this purpose, dissociated
tissues were divided into portions to achieve the appropriate dilution (0.01-
1.00 ee); each portion was co-aggregated separately with 105 OP9 cells and
allowed to mature in culture. Based on the principle of quantitative limiting
dilution analysis, we have to use doses of cells sufficiently low to obtain
some statistically significant numbers of co-aggregates with and without
pre-HSCs. As a result, by the end of culture, some co-aggregates will
contain and some will not contain dHSCs. Transplanting individual co-
aggregates into separate recipients gave us the number of co-aggregates that
originally (before culture) contained pre-HSCs, independently of their
proliferative activity inside the co-aggregate. This is because all the progeny
of the pre-HSC remains in the same co-aggregate and goes only into one
recipient mouse. Using Poisson’s statistics (ELDA software; Hu and Smyth,
2009) based on numbers of repopulated versus total transplanted recipients,
we could calculate the number of pre-HSCs in a given embryonic tissue.
For culture, E9.5-E12.5 embryonic tissues were dissociated with
collagenase/dispase and then co-aggregated in limiting dilutions with 105
OP9 cells using 30 μl culture medium [Iscove’s modified Dulbecco’s
medium (IMDM; Invitrogen-GIBCO), 20% of preselected, heat-inactivated
foetal calf serum (PAA/HyClone) and L-glutamine, penicillin/
streptomycin]. Cells were centrifuged at 450 g for 12 min in 200 μl
pipette tips sealed with parafilm as described previously (Rybtsov et al.,
2014; Sheridan et al., 2009). Media was supplemented with growth factors
expressed in the AGM region [SCF (Kitl), Flt3, IL3 at 100 ng/ml each;
PeproTech]. Co-aggregates were cultured on floating 0.8-μmAAWP 25-mm
nitrocellulose membranes (Millipore) for 24 h, then medium was replaced
and cultures incubated for an additional 6 days. Co-aggregates were
dissociated using collagenase/dispase. All experiments were performed at
least twice independently.
Throughout this study, pre-HSC_LDA was mainly used without
distinction (no cell purification) between types of pre-HSCs (Fig. 1D;
Fig. 2). However, when quantification of individual pre-HSC types was
required, we sorted these populations and subjected them to preHSC_LDA
(Table S1). Mice with donor-derived chimerism >5% following 13.5-
18 weeks post-transplantation were considered to be repopulated (Table S2).
Statistical analysis
The number of pro-HSCs and HSCs and the 95% confidential interval were
calculated by the single-hit Poisson model using ELDA software (Hu and
Smyth, 2009). Coefficients for polynomial regression equation were
calculated in Excel (Microsoft). Polynomial regressions were calculated
and close correlation with experimental data (R2 is 0.84-0.98) (P>0.01) were
found (x-axis: somites pairs number; y-axis: pre-HSC/HSC number) (Fig. 2;
Table S2).
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